ImmuneCyte, Inc.

ImmuneCyte Inc. is a global, clinical-stage biopharmaceutical company engaged in the research and development of innovative cell and gene therapeutics, including the fourth generation chimeric antigen receptor (CAR)-T cell, CAR-NK cell, and mononuclear cell therapies, for the treatment of cancer and vascular diseases. With global coronavirus pandemic, ImmuneCyte is also developing a multitiered immunotherapies in the fight against Covid-19. Connect with us at www.immunecyte.com, on Facebook at www.facebook.com/ImmuneCyte and on Instagram @ImmuneCyte.

网站

https://immunecyte.com/

ImmuneCyte, Inc.的外部链接

所属行业

生物技术

规模

51-200 人

总部

Irvine，California

类型

私人持股